Ichthyosis vulgaris (IV) is the most common hereditary disorder of cornification in humans, characterized by generalized fine scaling of the skin, palmar hyperlinearity with or without keratosis pilaris and atopy. Recently, the molecular basis of IV was ascribed to loss-of-function mutations in the gene encoding filaggrin (FLG), namely p.R501X and c.2282del4. Homozygotes and compound heterozygotes were severely affected whereas heterozygotes showed mild disease or were asymptomatic, suggesting semidominant inheritance with incomplete penetrance in heterozygotes. We report the presence of FLG mutations in 15 out of 21 IV patients with a marked generalized scaling phenotype, including eight affected members of a four-generation family. In this group of patients not only homozygous and compound heterozygous, but also heterozygous patients for p.R501X and c.2282del4 display a pronounced phenotype, whereas in none of six individuals these two mutations were detectable despite decreased filaggrin expression on immunohistochemistry in two patients, indicating that other mutations in FLG and/or in other genes remain to be identified. In contrast, two additional p.R501X heterozygotes from the extended family are asymptomatic. In a control population from west-Austria a combined p.R501X and c.2282del4 carrier frequency of 6/110 (5.45%) was observed. We confirm that these FLG variants are common, but our results point to the existence of additional modifiers.
Introduction
Ichthyoses are a heterogenous group of inherited scaling disorders caused by abnormal cornification. Of these, ichthyosis vulgaris (IV, OMIM 146700) is the most common entity with a reported incidence between 1:250 and 1:5300. 1 -4 Individuals with IV are characterized by a life-long history of generalized fine scaling that is accentuated on the extensor surfaces of the extremities and typically spares the great flexures and the neck. Associated findings include hyperkeratosis and hyperlinearity of the palms ('I-hand') and soles, 5 keratosis pilaris, 6 hypohydrosis, 7 atopic dermatitis (AD), 8 allergic rhinoconjunctivitis and asthma. 7, 9 Histologically, the epidermis of IV subjects is characterized by hyperkeratosis and an attenuation or absence of the granular layer; 10 -12 however, in approximately 25 -50% of patients diagnosed with IV based on clinical criteria the stratum granulosum is histologically normal. 1, 13, 14 Abnormal keratohyalin granules in the granular layer have been observed on electron microscopy 15 and decreased epidermal (pro)filaggrin expression has been described as a hallmark of the disease. 13, 16 Recently, two loss-of-function mutations in exon 3 of the gene encoding filaggrin (FLG) have been reported to cause the skin abnormalities in IV. 17 These mutations were described to be inherited in a semidominant pattern with heterozygotes presenting a moderate phenotype with 90% penetrance and homozygotes and compound heterozygotes showing a severe phenotype. 17 These findings prompted us to evaluate a cohort of Central European IV patients including an extended multi-generation family for mutations in FLG and the corresponding clinical phenotype.
Subjects and methods

Affected individuals and phenotypes
Thirteen unrelated patients with IV as well as eight affected and 16 unaffected members of an extended four-generation family ( Figure 1 ) were included in this study. With the exception of two individuals of Turkish and Indian ancestry, respectively, the patients were of Austrian and Dutch descent (Table 1) . Phenotypes were determined by thorough physical examination by two experienced dermatologists. After obtaining written informed consent (protocol approved by Innsbruck Medical University Ethics Committee on Human Research and carried out in accordance with the declaration of Helsinki), venous blood samples were collected from IV patients and family members. Skin biopsies were obtained from affected individuals and processed for routine light microscopy by hematoxylin/eosin staining and for immunohistochemistry. To exclude X-linked recessive ichthyosis, male patients were tested for steroid sulfatase (STS) deficiency by both lipid electrophoresis and STS-deletion-fluorescence in situ hybridization (FISH) using the LSI-steroid sulfatase probe (Vysis, Abbott, Vienna, Austria). 18 DNA samples from 110 randomly selected, anonymous and unrelated healthy blood donors were subjected to mutation screening as described below.
Immunohistochemistry
For immunohistochemistry, we used the filaggrin mouse monoclonal antibody of Novocastra Laboratories Ltd (Newcastle upon Tyne, UK) in a working dilution of 1:25 and the high-temperature antigen unmasking technique according to the manufacturer's instructions.
Molecular analysis
Genomic DNA was extracted from EDTA blood samples by using the QIAamp DNA Mini Kit (Qiagen, Vienna, Austria) or the GenoM48 automated extractor (Qiagen, Vienna, Austria) according to the protocols of the manufacturer. For the analysis of the published p.R501X (c.1501C4T) mutation localized in exon 3 of the FLG gene, genomic DNA was amplified by using Promega PCR buffer, Promega Taq polymerase mix and the published primer pair FilH1F3/RPT1P6 17 using the PTC-100 Peltier Thermal
Cycler (MJ Research, USA). PCR conditions were as follows: 941C for 5 min; 35 cycles of 941C for 40 s, 581C for 1 min, 721C for 1 min 30 s; final extension step at 721C for 7 min. The p.R501X mutation creates a Hin1II (NlaIII) restriction site, and all samples were screened by restriction digest (Hin1II, Fermentas) of PCR products (3 h at 371C) followed by 3% agarose gel electrophoresis. Amplified PCR products from three different index patients were also resolved on 1.5% agarose gels, purified by Ultrafree-DA (www.millipore. com) and sequenced using the Big Dye Terminator protocol.
Similarly, for analysis of the c.2282del4 mutation localized in exon 3 genomic DNA was amplified by using Promega PCR buffer, Promega Taq polymerase mix and the 
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R Gruber et al published primer pair RPT1P7/RPT2P1 17 using the following PCR settings: 941C for 5 min; 35 cycles of 941C for 40 s, 571C for 1 min, 721C for 2 min; final extension step at 721C for 7 min. The c.2282del4 mutation creates a new AdeI (DraIII) restriction site, and the samples were screened by restriction digest of PCR products using 5 U AdeI for 3 h at 371C and 2.5% agarose gel electrophoresis. Amplified PCR products from three probands were also electrophoresed on 1.5% agarose gels, purified by Ultrafree-DA (www.millipore. com) and sequenced using the Big Dye Terminator protocol to confirm the mutation.
Results
After excluding X-linked recessive ichthyosis (OMIM þ 308100) in all male individuals by lack of accelerated low-density lipoprotein migration on serum lipid electrophoresis and exclusion of a microdeletion within the STS gene (Xp22. 3) by FISH, we assessed the severity of the IV phenotype of thirteen patients and an extended family with eight affected family members (Figure 1 ) by clinical examination. There was considerable variation in the degree of generalization and in the intensity of scaling (Table 1) . Although the skin of 10 patients was characterized by fine, whitish scaling primarily on the extensor surfaces of the extremities, the other 11 patients showed a severe expression of IV with generalized fine to coarse scaling and marked palmoplantar keratoderma. Six Filaggrin mutations in ichthyosis vulgaris R Gruber et al patients (29%) had atopic dermatitis (erythematous, scaly plaques) with or without asthma and/or allergic rhinitis, of whom two carried FLG mutations. Light microscopy of skin biopsies from members of the extended IV pedigree with the pronounced IV-phenotype all revealed absence of the granular layer regardless of body site ( Figure 2 ). Next, we screened our cohort of patients for the two reported loss-of-function mutations in exon 3 of the FLG Figure 4 Immunohistochemistry using an antibody directed against the C-terminal filaggrin repeats. 
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R Gruber et al gene, namely p.R501X and c.2282del4 by using restriction enzyme digestion (Figure 3 ). Of 13 unrelated patients with generalized scaling, three were homozygous or compound heterozygous, and four were heterozygous for one of the mutations. Six IV patients showed neither mutation, but showed the clinical signs of IV and two of them exhibited variable degrees of decreased FLG expression on immunohistochemistry (Figure 4e and f) . Furthermore, among eight affected relatives of the extended family, one was homozygous and seven individuals were heterozygous for p.R501X. Within this pedigree, two of 16 family members with no discernible IV phenotype ( Figure 1 ) were found to be heterozygous for p.R501X, corresponding to a penetrance of this mutation of 83%. Finally, in a panel of control samples we observed a carrier frequency of 3/110 (2.7%) for the variant p.R501X and 3/110 (2.7%) for the variant c.2282del4, respectively.
Discussion
Recently, the FLG mutations p.R501X or c.2282del4 were identified in all of seven unrelated families and eight sporadic IV patients of Irish, Scottish and EuropeanAmerican origin. 17 We identified six p.R501X and five c.2282del4 alleles in eight of 14 unrelated IV patients, confirming that FLG mutations are a major cause of IV in patients from Central Europe (Austria and The Netherlands) ( Table 1) . A semidominant mode of inheritance of IV was exemplified by multiple examples of p.R501X heterozygous patients with very mild presentation as well as by p.R501X homozygotes and p.R501X/c.2282del4 compound heterozygotes with the full ichthyosis vulgaris phenotype. 17 Yet, in our IV cohort five patients heterozygous for p.R501X displayed a pronounced ichthyosis phenotype. Conversely, six patients showed neither p.R501X nor c.2282del4 (Table 1) despite generalized scaling and although two of them showed diminished filaggrin expression on immunohistochemistry (Figure 4e and f) . Together, these results raise the possibility of additional allelic or non-allelic mutations in these patients. However, FLG sequencing in the five heterozygous patients and in the two patients of non-European ancestry is slowed by difficulties owing to the length and repetitive nature of this gene. 17 Alternatively, it is also possible that other cornified envelope proteins, encoded adjacent to FLG in the epidermal differentiation complex including filaggrin 2, trichohyalin, hornulin, repetin or cornulin harbor mutations in these patients. Finally, the generalized scaling phenotype in these patients could result from variants in independent genes outside the epidermal differentiation complex reminiscent of the genetic heterogeneity in autosomal recessive ichthyoses.
Based on our data, the penetrance of IV in heterozygotes can be estimated at 83%, comparable to the 90% stated by Smith et al 17 on the basis of their seven families; however, these penetrance estimates derive from selected families and may be biased towards higher values. The association of IV with atopic diathesis is well established; one-third to one-half of patients with IV show concurrent atopic disease, 8, 19 Whether these high mutation frequencies are owing to founder mutations or recurrent de novo mutations, for example, the p.R501X mutation concerns a CpG site, will be addressed by haplotype studies in patients from different populations.
